Clinical Trials Logo

Renal Cell Carcinoma, Clear Cell clinical trials

View clinical trials related to Renal Cell Carcinoma, Clear Cell.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05585034 Recruiting - Colorectal Cancer Clinical Trials

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Start date: December 14, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous (IV) administration of XmAb808 in combination with pembrolizumab in subjects with selected advanced solid tumors and to identify the minimum safe and biologically effective/recommended dose (RD) and schedule for XmAb808.